or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Amy Klobuchar's Public Statements on Issue: Drugs

Full Name: Amy Klobuchar
Office: U.S. Senate (MN) - Sr, Democratic/Farmer/Labor
First Elected: 11/07/2006
Last Elected: 11/06/2012
Next Election: 2018
Gender: Female
Family: Husband: John; 1 Child: Abigail
Birth Date: 05/25/1960
Birth Place: Plymouth, MN
Home City: Minneapolis, MN
Religion: Congregationalist
Date Title
April 14, 2014 Klobuchar, Heitkamp in Mexico to Discuss Joint Efforts to Fight Sex Trafficking, Heroin Epidemic
April 10, 2014 Time - The Rise of Fake Pot
April 4, 2014 Klobuchar: FDA Approval of Drug to Reverse Heroin Overdoses is Important Step in Effort to Save Lives
April 2, 2014 Klobuchar Presses DEA to Immediately Implement Law to Help Curb Prescription Abuse, Combat Growing Heroin Epidemic
April 1, 2014 Protecting Volunteer Firefighters and Emergency Responders Act of 2014
March 17, 2014 Klobuchar Bipartisan Resolution Designating National Youth Synthetic Drug Awareness Week Passes House
Feb. 16, 2014 Klobuchar Leads Roundtable Discussion to Highlight Efforts to Combat Heroin Use in Minnesota
Feb. 10, 2014 After Klobuchar Passes Legislation to Fight Drug Shortages, FDA Reports It Prevented At Least 140 Shortages in 2013, Helped Reduce Number of New Shortages by Over 65%
Sept. 26, 2013 Klobuchar Highlights Her Work to Fight Dangerous Synthetic Drugs
July 18, 2013 Klobuchar, Graham, Feinstein Introduce Legislation to Help Fight New Synthetic Drugs
May 6, 2013 Letter to Dr. Margaret Hamburg, Commissioner for the U.S. Food and Drug Administration - End Infant Drug Shortage
May 3, 2013 Letter to Mary Jane Helenek, President and CEO of Luitpold Pharmaceuticals, Inc., Michael Ball, CEO of Hospira Inc., and John Ducker, President and CEO of APP Pharmaceuticals - End Shortage of Critical Drugs Used to Treat Infants in Intensive Care
Feb. 5, 2013 Klobuchar, Grassley Reintroduce Legislation to Crack Down on Anti-Competitive Pay-for-Delay Deals
Sept. 19, 2012 Letter to Chairwoman Mikulski and Ranking Member Hutchison
July 11, 2012 Park Rapids Enterprise - Synthetic Drug Ban Good News
July 9, 2012 WDIO.com - Bill Containing Klobuchar Synthetic Drug Language Signed
July 9, 2012 Inforum - Obama Signs Bill to Ban Synthetic Drugs
July 9, 2012 Klobuchar's Bipartisan Provisions Banning Dangerous Synthetic Drugs Signed Into Law
June 26, 2012 KEYC.TV - Drug Bill Passes Senate
June 26, 2012 Klobuchar's Bipartisan Provisions Banning Dangerous Synthetic Drugs Headed to President's Desk to be Signed Into Law
June 15, 2012 Letter to the Honorable Tom Harkin, Chairman on the Committee on Health, Education, Labor, and Pensions, the Honorable Michael B. Enzi, Ranking Member Committee on Health, Education, Labor, and Pensions, the Honorable Fred Upton, Chairman on the Committee on Energy and Commerce, and the Honorable Henry A. Waxman Ranking Member Committee on Energy and Commerce
June 8, 2012 Letter to Chairman Harkin, Ranking Member Enzi, Chairman Upton, and Ranking Member Waxman
May 24, 2012 Klobuchar's Bipartisan Amendment to Ban Dangerous Synthetic Drugs Passes Senate
May 21, 2012 Klobuchar Calls on Senate Colleagues to Swiftly Pass Legislation to Prevent Critical Drug Shortages
April 25, 2012 Klobuchar's Bipartisan Provisions to Prevent Drug Shortages, Boost Medical Device Innovation Clear Senate Committee
March 26, 2012 Rochester Post Bulletin - Feds Serious on Halting Synthetic Drug Trafficking
Feb. 21, 2012 Klobuchar: Shortage of Critical Childhood Cancer Drug Averted, Calls on Congress to Pass Drug Shortage Legislation to Help Prevent Future Shortages
Feb. 15, 2012 Synthetic Drug Use
Feb. 15, 2012 Klobuchar, Grassley, Schumer Urge Passage of Bipartisan Synthetic Drug Bills
Feb. 14, 2012 Klobuchar, Casey, Collins Offer Amendment to Push Urgent Drug Legislation Forward
Feb. 13, 2012 Letter to Hospira, Inc., Mylan, Inc., Sandoz, Inc. and APP Pharmaceuticals
Jan. 26, 2012 Drug Shortages
Dec. 15, 2011 As Klobuchar Testifies in Support of Bipartisan Drug Shortages Legislation, FDA Announces Key Rule Change Advancing Bill
Dec. 14, 2011 Klobuchar Statement on New Report Regarding Teen Use of Synthetic Drugs
Dec. 9, 2011 Statement on House Passage of Legislation Banning Synthetic Drugs
Dec. 1, 2011 Letter to Margaret Hamburg, M.D., Commissioner of U.S. Food and Drug Administration
Nov. 10, 2011 Klobuchar Calls for Hearing to Address Critical Drug Shortages Problem
Nov. 9, 2011 Attorney General Holder Voices Support for Klobuchar's Synthetic Drug Legislation
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner
Oct. 31, 2011 Drug Shortages
Oct. 31, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2012
Oct. 31, 2011 Klobuchar-Casey Bipartisan Drug Shortage Legislation Advanced by President's Executive Order
Oct. 6, 2011 Echo Press - Legislation Aims to Ban Dangerous Synthetic Drugs
Sept. 26, 2011 Letter to Secretary Sebelius, Health and Human Services
Sept. 7, 2011 Klobuchar Statement on DEA Decision Banning Synthetic Stimulants in "Bath Salts'
Sept. 1, 2011 Klobuchar Holds Roundtable on Synthetic Drugs
July 28, 2011 Klobuchar Bipartisan Bills Banning Dangerous Synthetic Drugs Clear Committee
July 21, 2011 Senators Klobuchar, Tom Udall, and Shaheen Introduce Legislation to Crack Down on Criminals Using Prepaid Debit Cards to Finance Illegal Activities
July 21, 2011 Senators Klobuchar, Tom Udall, and Shaheen Introduce Legislation to Crack Down on Criminals Using Prepaid Debit Cards to Finance Illegal Activities
July 12, 2011 Klobuchar and American Hospital Association Continue Push For Solutions to Drug Shortage Crisis
Back to top